The effect of mouthrinses on severe acute respiratory syndrome coronavirus 2 viral load : A systematic review
Copyright © 2022 American Dental Association. Published by Elsevier Inc. All rights reserved..
BACKGROUND: Considering that the oral cavity is a major entryway and reservoir for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the aim of the authors was to perform a systematic review of in vivo and in vitro studies to assess the effectiveness of mouthrinses on SARS-CoV-2 viral load.
TYPES OF STUDIES REVIEWED: The authors searched PubMed, Web of Science, Scopus, MedRxiv, and bioRxiv databases, including in vitro and in vivo studies assessing the virucidal effect of mouthrinses on SARS-CoV-2 or surrogates. From a total of 1,622 articles retrieved, the authors included 39 in this systematic review.
RESULTS: Povidone-iodine was the most studied mouthrinse (14 in vitro and 9 in vivo studies), frequently showing significant reductions in viral load in in vitro assays. Similarly, cetylpyridinium chloride also showed good results, although it was evaluated in fewer studies. Chlorhexidine gluconate and hydrogen peroxide showed conflicting results on SARS-CoV-2 load reduction in both in vitro and in vivo studies.
PRACTICAL IMPLICATIONS: Povidone-iodine-based mouthrinses appear to be the best option as an oral prerinse in the dental context for SARS-CoV-2 viral load reduction. Although the results of primary studies are relevant, there is a need for more in vivo studies on mouthrinses, in particular, randomized controlled clinical trials, to better understand their effect on SARS-CoV-2 viral load and infection prevention.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:153 |
---|---|
Enthalten in: |
Journal of the American Dental Association (1939) - 153(2022), 7 vom: 15. Juli, Seite 635-648.e16 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Silva, António [VerfasserIn] |
---|
Links: |
---|
Themen: |
85H0HZU99M |
---|
Anmerkungen: |
Date Completed 29.06.2022 Date Revised 30.06.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.adaj.2021.12.007 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM338186794 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM338186794 | ||
003 | DE-627 | ||
005 | 20231226000116.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.adaj.2021.12.007 |2 doi | |
028 | 5 | 2 | |a pubmed24n1127.xml |
035 | |a (DE-627)NLM338186794 | ||
035 | |a (NLM)35287944 | ||
035 | |a (PII)S0002-8177(21)00786-8 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Silva, António |e verfasserin |4 aut | |
245 | 1 | 4 | |a The effect of mouthrinses on severe acute respiratory syndrome coronavirus 2 viral load |b A systematic review |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.06.2022 | ||
500 | |a Date Revised 30.06.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 American Dental Association. Published by Elsevier Inc. All rights reserved. | ||
520 | |a BACKGROUND: Considering that the oral cavity is a major entryway and reservoir for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the aim of the authors was to perform a systematic review of in vivo and in vitro studies to assess the effectiveness of mouthrinses on SARS-CoV-2 viral load | ||
520 | |a TYPES OF STUDIES REVIEWED: The authors searched PubMed, Web of Science, Scopus, MedRxiv, and bioRxiv databases, including in vitro and in vivo studies assessing the virucidal effect of mouthrinses on SARS-CoV-2 or surrogates. From a total of 1,622 articles retrieved, the authors included 39 in this systematic review | ||
520 | |a RESULTS: Povidone-iodine was the most studied mouthrinse (14 in vitro and 9 in vivo studies), frequently showing significant reductions in viral load in in vitro assays. Similarly, cetylpyridinium chloride also showed good results, although it was evaluated in fewer studies. Chlorhexidine gluconate and hydrogen peroxide showed conflicting results on SARS-CoV-2 load reduction in both in vitro and in vivo studies | ||
520 | |a PRACTICAL IMPLICATIONS: Povidone-iodine-based mouthrinses appear to be the best option as an oral prerinse in the dental context for SARS-CoV-2 viral load reduction. Although the results of primary studies are relevant, there is a need for more in vivo studies on mouthrinses, in particular, randomized controlled clinical trials, to better understand their effect on SARS-CoV-2 viral load and infection prevention | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Systematic Review | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Saliva | |
650 | 4 | |a decision making | |
650 | 4 | |a infection control | |
650 | 4 | |a microbiology | |
650 | 4 | |a public health | |
650 | 7 | |a Mouthwashes |2 NLM | |
650 | 7 | |a Povidone-Iodine |2 NLM | |
650 | 7 | |a 85H0HZU99M |2 NLM | |
700 | 1 | |a Azevedo, Maria |e verfasserin |4 aut | |
700 | 1 | |a Sampaio-Maia, Benedita |e verfasserin |4 aut | |
700 | 1 | |a Sousa-Pinto, Bernardo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of the American Dental Association (1939) |d 1946 |g 153(2022), 7 vom: 15. Juli, Seite 635-648.e16 |w (DE-627)NLM000071870 |x 1943-4723 |7 nnns |
773 | 1 | 8 | |g volume:153 |g year:2022 |g number:7 |g day:15 |g month:07 |g pages:635-648.e16 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.adaj.2021.12.007 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 153 |j 2022 |e 7 |b 15 |c 07 |h 635-648.e16 |